Laura Kovanda
Center for Global Development(US)Astellas Pharma (United States)(US)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Fungal Infections and Studies, Pneumocystis jirovecii pneumonia detection and treatment, Cystic Fibrosis Research Advances, Helminth infection and control
Most-Cited Works
- → Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis(2007)630 cited
- → The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation(2017)382 cited
- → Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials(2010)223 cited
- → Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses(2016)211 cited
- → The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants(2006)182 cited
- → Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial(2018)176 cited